Skip to main content

Table 2 Clinical outcomes of patients with versus without diabetes mellitus in the unmatched population

From: Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis

 

Diabetes

(n = 3550)

No diabetes

(n = 7890)

RR

(95% CI)

p Value

Procedural

    

Conversion to open heart surgery

21 (0.7%)

55 (0.8%)

0.9 (0.5–1.4)

0.54

Mortality < 72h

137 (1.7%)

51 (1.4%)

1.2 (0.9–1.7)

0.24

During hospital admission

    

Mortality

157 (4.5%)

380 (4.9%)

0.9 (0.8–1.1)

0.43

Stroke

60 (1.7%)

159 (2.0%)

0.8 (0.6–1.1)

0.27

Myocardial infarction

31 (0.9%)

51 (0.7%)

1.4 (0.9–2.1)

0.18

Major or life-threatening bleeding

198 (6.1%)

480 (6.7%)

0.9 (0.8–1.1)

0.25

New onset atrial fibrillation

76 (8.0%)

180 (6.8%)

1.1 (0.9–1.5)

0.23

Permanent pacemaker implantation

428 (13.3%)

940 (13.1%)

1.0 (0.9–1.1)

0.74

Length of stay (days)

7 (5–11)

7 (5–11)

-

0.96

At 30 Days

    

Mortality

171 (5.4%)

439 (6.1%)

0.9 (0.8–1.1)

0.19

Stroke

72 (2.3%)

185 (2.6%)

0.9 (0.7–1.2)

0.40

At one year

    

Mortality

394 (17.5%)

874 (17.4%)

1.0 (0.9–1.1)

0.86

Stroke

114 (5.0%)

274 (5.4%)

0.9 (0.8–1.2)

0.53

  1. Incidence and relative risk of clinical outcomes in diabetic compared with non-diabetic patients. RR: Relative Risk; CI: Confidence Interval